Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

JNJ 78991172

Next Previous
X
Search
Drug Profile

JNJ 78991172

Alternative Names: JNJ-78991172; RSV-B preF protein vaccine - Janssen Vaccines and Prevention B.V; RSV-B preF vaccine

Latest Information Update: 10 Mar 2023

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Janssen Vaccines and Prevention B.V
  • Class Protein vaccines; Respiratory syncytial virus vaccines; Synthetic vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Respiratory syncytial virus infections

Most Recent Events

  • 16 Jan 2023 Janssen Vaccines and Prevention B.V terminates a phase-I/II trial in Respiratory syncytial virus infections (In the elderly, Prevention, In adults) in Spain, USA (IM) based on recent study data for JNJ 64400141 (NCT05327816) (Eudra2022-001015-14)
  • 05 Oct 2022 Phase-I/II clinical trials in Respiratory syncytial virus infections (In the elderly, Prevention, In adults) in Spain (IM) (NCT05327816) (Eudra2022-001015-14)
  • 13 Apr 2022 Phase-I/II clinical trials in Respiratory syncytial virus infections (In adults, In the elderly, Prevention) in USA (IM) (NCT05327816)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top